Rutundine

罗通定

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRutundine
Drug Alias Name颅通定L-TetrahydropalmatineHyndarin颅痛定Caseanine +[13
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors antagonists
TargetsDopamine receptors
Therapy Area/IndicationsPain
Global Approved IndicationsPain
Approved Indications in ChinaPain
Original Approved Country/TerritoryMainland China
Original Approved Date1982/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN02
Related LinksN/A